Health Equity Focus Points: June 2023


Davey Daniel, MD, on the importance of health equity at OneOncology

“Physicians have an obligation to provide equitable and equitable care to the diverse patient population in their community,” said Davey Daniels, Chief Medical Officer of OneOncology. Evidence-based oncology (EBO) at the recent Community Oncology Alliance Community Oncology Conference.

EBO: How does OneOncology approach health equity in all of its practices?

Daniel: Health equity is what community oncology is all about. We see every patient that walks through the door. We are committed to…[the] Because we live, practice, and…most of our patients are local, we are indeed very different from…academic institutions—and sometimes even hospital systems. We… have an obligation.

When we talk about health equity and when we talk about health equity with pharmacy, it’s a way to achieve health equity in research and care. [that] You make the research available at practice level at multiple sites, not just in large clinics where you can hire more people in financially well-off communities. You should make those tests available where patients are treated. So, for different patients, it should be…[at] Many sites…[in] More cities than the entire country…[in] Only a few academic centers.

Samyukta Mullangi, MD, MBA: Cancer care navigation platforms can reduce VBC system operational, financial challenges.

Partnering with care navigation platforms like Thyme Care can be beneficial for oncology practices, especially small or rural clinics, to address the operational and financial risks associated with transitioning from fee-for-service (FFS) to value-based care (VBC) systems. , according to Samyukta Mullangi, MD, MBA. Mulangi spoke. Evidence-based oncology (EBO) is incoming medical director at Thyme Care after completing an oncology fellowship at Memorial Sloan Kettering Cancer Center in New York City, New York.

EBO: Can you speak to the operational and financial challenges of transitioning from FFS to VBC and why it would be beneficial to partner with companies like Thyme Care to improve these issues?

Mulangi: Apprenticeships are moving from FFS to VBC for good reason. There are many tailwinds that turn you in this direction. [and] Almost all of them are related to the fact of the cost of health care[ing] It is taking the lion’s share of every dollar spent in this economy.

That being said, the move to VBC is a big operational move for practices. Even short of participating in fully paid premiums, the adoption of risk-sharing agreements with insurers represents a complete change in attitude. Part of the problem is that practices—and this is true not only in cancer, but in cancer—are not equipped with the right technological tools to monitor public health, nor are they staffed enough to deal with problems that arise in an organized way. Surveys or the like.

So let me explain in detail [technology] First piece. Today’s oncologists, no matter what the EMR [electronic medical record] They use, they can’t tell you the basics [such as] What is the size of their panel, how many patients are on active treatment, how many patients have passed primary therapy in the metastatic setting. No EMR is computing things systematically. [such as] Poor outcomes or palliative performance measures that may signal the need for advanced care planning or palliative care. [consultations]example.

If patients are admitted or seen in an emergency [department] At a local hospital, oncologists only know this if they have a good but informal relationship with the hospital’s case manager or if the patient or family tells them directly. And that is the situation today; Monitoring public health is difficult without a bird’s eye view of your population.

The staff is equally important. Effective VBC and public health require oncologists to periodically check in on how their patients are doing in terms of their symptoms, especially if they are on active treatment. You’ve heard of electronic patient-report results [ePROs]; This is becoming more and more normal. For example, CMS’ upcoming Enhancing Oncology Model requires practices to have a system in place to collect ePROs from their patients on a regular and regular basis.

It is also important to identify social determinants of health, as these play a significant role in how patients fare and how they stay on treatment. However, additional manpower is sometimes required to address issues that may arise during these periodic reviews. And [although] While larger clinics may be able to accommodate and accommodate these new responsibilities into existing staffing structures, it is more difficult for smaller or rural clinics. These new requirements may perpetuate health inequities.

Thyme Care tries to solve both. That’s why. [technology] The platform enables the identification of the patient’s conscious intelligence. ePROs has a platform that assesses battery symptoms and provides information on social determinants of health. And the way the care model is structured is that there are systematic reviews of patient activities. All this is supported by teams of nurses and nurses and is under the supervision of the medical director [all] Completely remote and centralized.

of [technology] And it represents the human resources that Thyme Care can provide[s] Skills that are too expensive or difficult for any clinic to replicate on their own. In fact, there is no need. When there are such solutions in the market, I think that practices should be partners instead of trying to reinvent the wheel.


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *